Stock Price Forecast

March 15, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading XBiotech Inc chart...

About the Company

xbiotech is developing a first-in-class monoclonal antibody (mabp1) to inhibit chronic inflammation. chronic (sterile) inflammatory responses are involved in the progression of many serious and common diseases. mabp1 is being investigated in many important areas of medicine, including: cancer, leukemia (phase 1); type 2 diabetes (phase2); psoriasis (phase 2); and vascular disease (phase 2). mabp1 is a true human™ antibody cloned from a natural human immune response and—unlike currently marketed antibodies—it has not undergone any modification to alter its function. it has exhibited the best potential tolerability and safety during the clinical trials. xbiotech has established a current good manufacturing practices (cgmp) program to commercialize its lead product candidate. the company has purchased land and designed a commercial-scale plant with 25,000l total bioreactor capacity. construction of the facility is planned to commence in 4th quarter 2011..

CEO

John Simard

Exchange

NASDAQ

Website

http://www.xbiotech.com/

$32M

Total Revenue

111

Employees

$180M

Market Capitalization

-3.52

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $XBIT News

XBiotech Inc.'s (NASDAQ:XBIT) top owners are retail investors with 44% stake, while 44% is held by insiders

23d ago, source: Yahoo Finance

XBiotech's significant retail investors ownership ... Insiders own 44% of XBiotech A look at the shareholders of XBiotech Inc. (NASDAQ:XBIT) can tell us which group is most powerful.

XBiotech Inc XBIT

5d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

XBiotech Inc 4XB

24d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

The Zacks Analyst Blog Highlights Quince Therapeutics and XBiotech

10d ago, source:

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks ...

XBiotech Inc (XBIT) Earnings Dates & Reports

7mon ago, source: Investing

View upcoming earnings forecasts and in-depth analysis of company forecasts.

Welcome to Inc.'s Directory of B2B Excellence

4mon ago, source: Inc

They all made it through Inc.'s proprietary vetting process, based in part on testimonials from other clients. As any entrepreneur knows, the right partnership can make all the difference.

STIHL Inc.

7mon ago, source: Forbes

This company has paid to receive expanded profile features. About STIHL Inc. Virginia-based STIHL Inc. is the U.S. affiliate for the global STIHL group and the manufacturer of the number one ...

Stocks A-Z

1y ago, source: MarketWatch

China XSHG Banking Xiamen C&D Inc. A (600153) China XSHG Transportation Services Xiamen Changelight Co. Ltd. (300102) China XSHE Industrial Electronics Xiamen Comfort Science & Technology Group Co ...

Block Inc.

5mon ago, source: Wall Street Journal

1 Day SQ -1.32% DJIA -0.49% S&P 500 -0.65% Technology -1.75% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum ...

XBiotech Inc.'s (NASDAQ:XBIT) top owners are retail investors with 44% stake, while 44% is held by insiders

22d ago, source: Yahoo Finance

However, on some occasions too much power is concentrated within this group. Our information suggests that insiders maintain a significant holding in XBiotech Inc.. Insiders have a US$86m stake in ...

XBiotech Inc.

5mon ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...